-
Standardized Whole-Blood Stimulation Unveils Immunometabolic
2026-06-19
This protocol study introduces a rigorous framework for analyzing human immune responses via standardized whole-blood stimulation combined with metabolic modulation. By enabling reproducible assessment of how metabolic pathways regulate cytokine production, the research advances immunometabolism studies and supports translational immune intervention strategies.
-
BR101801–Venetoclax Synergy in DLBCL via Triple Targeting Pa
2026-06-18
This study demonstrates that combining BR101801, a PI3K/DNA-PK inhibitor, with Venetoclax (ABT-199) yields potent synergistic antitumor effects in double-hit diffuse large B-cell lymphoma (DLBCL) by simultaneously targeting c-Myc, Bcl-2, and Mcl-1 pathways. The findings suggest a promising combinatorial approach to overcome resistance in aggressive DLBCL subtypes and inform future therapeutic strategies.
-
Pharmacokinetics and PK/PD Rationale for Cefazedone in CAP T
2026-06-18
This article examines a clinical pharmacokinetic and pharmacodynamic study evaluating intravenous Cefazedone for mild to moderate community-acquired pneumonia. The research demonstrates that a 2 g every 12 hours regimen achieves optimal fT>MIC and clinical cure rates, supporting its rational use for infections caused by susceptible bacteria.
-
SARS-CoV-2 Nucleocapsid Suppresses GADD34-Mediated Immunity
2026-06-17
This study elucidates how the SARS-CoV-2 nucleocapsid protein subverts host innate immunity by sequestering GADD34 mRNA in atypical foci, disrupting the IRF3-mediated antiviral response. The findings highlight a novel viral strategy with implications for antiviral research and potential therapeutic development.
-
Optimizing Excitotoxicity Assays with NMDA (N-Methyl-D-aspar
2026-06-17
This article provides a scenario-driven, evidence-based guide to maximizing the reliability and reproducibility of excitotoxicity and oxidative stress assays using NMDA (N-Methyl-D-aspartic acid), SKU B1624. Drawing from recent literature and practical laboratory challenges, we demonstrate how APExBIO’s high-purity NMDA supports robust modeling in neurodegenerative disease research and cell viability workflows.
-
Cy5-UTP: Advanced Strategies for Fluorescent RNA Labeling
2026-06-16
Cy5-UTP (Cyanine 5-UTP) elevates RNA labeling with unmatched sensitivity and workflow efficiency, enabling precise visualization in FISH, phase separation, and dual-color expression studies. Explore protocol enhancements, troubleshooting, and unique insights from neurodegeneration research that make this APExBIO reagent a premier choice.
-
Amyloid Beta-peptide (25-35): Frontiers in Translational AD
2026-06-16
This article explores the mechanistic and translational significance of Amyloid Beta-peptide (25-35) (Aβ25-35) in Alzheimer's disease modeling, delves into the emerging FLOT1-FOSL2-EphA2 axis, and provides actionable guidance for researchers seeking to bridge preclinical assays and therapeutic innovation. The discussion highlights how APExBIO’s rigorously validated Aβ25-35 peptide empowers reproducible neurotoxicity models, contextualizes recent mechanistic breakthroughs, and outlines strategic considerations for next-generation neurodegenerative disease research.
-
Ertapenem Sodium Salt: Experimental Workflows and Resistance
2026-06-15
Ertapenem sodium salt from APExBIO is a powerful tool for dissecting Gram-positive and Gram-negative multidrug resistance, enabling robust, high-fidelity experimental workflows. This guide delivers protocol enhancements, troubleshooting strategies, and practical insights, anchored in the latest gene transmission and resistance research.
-
InstaBlue Protein Stain Solution: Rapid, Fixation-Free Gel S
2026-06-15
InstaBlue Protein Stain Solution provides a rapid, ready-to-use method for sensitive protein detection in polyacrylamide gels, eliminating the need for fixation or destaining. It is best suited for workflows where speed, mass spectrometry compatibility, and preservation of protein integrity are essential. It is not designed for applications outside protein gel electrophoresis or for protocols requiring permanent gel archiving by fixation.
-
Pam3CSK4 TFA: Applied TLR1/2 Agonist Workflows in Immunity R
2026-06-14
Pam3CSK4 TFA enables precise TLR1/2 pathway activation for dissecting innate immune mechanisms and cytokine signatures, especially in maternal-neonatal contexts. This article delivers stepwise protocols, troubleshooting, and translational insights—backed by recent evidence—to streamline your immune signaling studies.
-
Single-Molecule Imaging Reveals R-Loop Impact on DNA Replica
2026-06-13
This study pioneers the direct visualization of replication fork and R-loop collisions using single-molecule fluorescence imaging. The findings elucidate how even a single R-loop can halt DNA replication, with implications for understanding genome instability and refining in vitro RNA labeling protocols.
-
Bazedoxifene as an Antimalarial: Inhibition of Hemozoin Form
2026-06-12
The referenced study demonstrates that Bazedoxifene, a third-generation selective estrogen receptor modulator, exhibits potent antimalarial activity by inhibiting Plasmodium falciparum growth and blocking hemozoin formation. These findings highlight its potential for drug repurposing in malaria treatment, bridging osteoporosis and infectious disease research.
-
NHS-Biotin (A8002): Precision Biotinylation in Multimeric Pr
2026-06-12
Explore how NHS-Biotin enables advanced, site-specific biotinylation for engineering multimeric and multispecific proteins. This article uncovers unique mechanistic insights and guides practical assay optimization, making it essential for researchers using N-hydroxysuccinimido biotin in cutting-edge protein engineering.
-
Rottlerin as a Selective PKC Inhibitor: Protocols and Innova
2026-06-11
Rottlerin’s role as a selective PKCδ inhibitor unlocks advanced control over apoptosis, cell proliferation, and viral entry assays. This article details robust protocols, translational applications, and troubleshooting tips, integrating insights from recent virology and cell biology studies to empower reproducible research.
-
GPR35-KLF5 Circuitry Orchestrates Epithelial Repair in UC Mo
2026-06-11
This study uncovers a metabolic gatekeeping mechanism in intestinal epithelial cells (IECs), wherein GPR35 senses kynurenic acid to trigger KLF5-driven repair programs following mucosal injury. The findings clarify how disruption of this pathway impairs mucosal healing, with implications for targeted ulcerative colitis interventions and experimental model design.